Skip to main content
Premium Trial:

Request an Annual Quote

Eric Neumann, Paul Grayson, Mark Zoller, Lubert Stryer, Saiid Zarrabian.

Premium

Eric Neumann, who recently left his post as vice president of life science informatics at 3rd Millennium of Cambridge, Mass., has been appointed vice president of bioinformatics at Beyond Genomics, also of Cambridge.

In this newly formed position, Neumann will handle all the informatics needs of the company, including genomics, proteomics, functional genomics, and metabolomics. He is currently building the company’s informatics team.

Senomyx of La Jolla, Calif., has appointed Paul Grayson chairman of the board and promoted Mark Zoller to the position of CSO.

Grayson, who is CEO of the company, and Zoller, who is vice president of research, will be replacing Lubert Stryer in his roles as chairman and CSO.

Earlier this month, Senomyx announced that Saiid Zarrabian, who resigned as chief operating officer at Pharmacopeia in December, had been appointed president and COO of Senomyx.

Zarrabian replaced Grayson in his previous role as president.

Filed under

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.